146 related articles for article (PubMed ID: 3406005)
1. Biological characteristics of N-myc amplified neuroblastoma in patients over one year of age.
Nakagawara A; Ikeda K; Tsuda T; Higashi K
Prog Clin Biol Res; 1988; 271():31-9. PubMed ID: 3406005
[TBL] [Abstract][Full Text] [Related]
2. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
[TBL] [Abstract][Full Text] [Related]
3. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
4. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P
Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672
[TBL] [Abstract][Full Text] [Related]
5. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma.
Nakagawara A; Ikeda K; Higashi K; Sasazuki T
Surgery; 1990 Jan; 107(1):43-9. PubMed ID: 2404349
[TBL] [Abstract][Full Text] [Related]
8. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
9. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
[TBL] [Abstract][Full Text] [Related]
10. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients.
Brodeur GM; Hayes FA; Green AA; Casper JT; Wasson J; Wallach S; Seeger RC
Cancer Res; 1987 Aug; 47(16):4248-53. PubMed ID: 2440561
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
12. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
13. [Management strategy in neuroblastoma].
Balwierz W
Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
[TBL] [Abstract][Full Text] [Related]
14. Increased N-myc expression following progressive growth of human neuroblastoma.
Rosen N; Reynolds CP; Thiele CJ; Biedler JL; Israel MA
Cancer Res; 1986 Aug; 46(8):4139-42. PubMed ID: 3731081
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human neuroblastoma cell lines that lack N-myc gene amplification.
Wada RK; Seeger RC; Brodeur GM; Slamon DJ; Rayner SA; Tomayko M; Reynolds CP
Prog Clin Biol Res; 1988; 271():57-69. PubMed ID: 3406020
[No Abstract] [Full Text] [Related]
16. [Tumor cytogenetics and prognosis in neuroblastoma].
Christiansen H; Lampert F
Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532
[TBL] [Abstract][Full Text] [Related]
17. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations involving chromosome 1p in children with neuroblastoma.
Avigad S; Tamir Y; Yaniv I; Goshen J; Kaplinsky C; Cohen IJ; Zaizov R
Isr J Med Sci; 1994 Aug; 30(8):639-41. PubMed ID: 7913920
[TBL] [Abstract][Full Text] [Related]
19. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
20. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]